FDA recall record

Dokitz NovoSci Cardiopulmonary bypass connector recall — FDA Z-0178-2015

The single leg of the PAY connector has been observed to become detached.

Class IIclassification
Z-0178-2015official record ID
Nov 12, 2014report date

Recall record at a glance

Official recordZ-0178-2015
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmDokitz NovoSci
Report dateNov 12, 2014
Recall initiation dateSep 18, 2014
Quantity240 units
LocationConroe, TX, United States

Official product description

Cardiopulmonary bypass connector; P/N: 321334-000 DESC: CONNECTOR, 3/8 X 3/8 X 1/2 CLEAR PAY LOT: 295424 STERILE Expiration May 2019 Manufacturing Date May 2014

Why the product was recalled

The single leg of the PAY connector has been observed to become detached.

Distribution information

MO, TX, PA, IL, MD, UT

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.